Clover Health Investments (NASDAQ: CLOV) reported Q3 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $331 million versus the consensus estimate of $346.27 million.

GUIDANCE:

Clover Health Investments sees FY2024 revenue of $1.35-1.37 billion, versus the consensus of $1.39 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.